Home > M&A deals 2011 > Alexion Pharmaceuticals, Inc. acquires Taligen Therapeutics, Inc.
Add-on Acquistion · Life Science · January 2011

Alexion Pharmaceuticals, Inc. acquires Taligen Therapeutics, Inc.

On January 28, 2011, Alexion Pharmaceuticals, Inc. acquired Taligen Therapeutics, Inc., a life science company in Massachusetts, United States, from Alta Partners.

Deal at a glance

AnnouncedJanuary 28, 2011 TypeAdd-on Acquistion TargetTaligen Therapeutics, Inc. Buyer Alexion Pharmaceuticals, Inc. Seller Alta Partners SectorLife Science LocationMassachusetts, United States ValueMembers only

Target company

Taligen Therapeutics, Inc.
Massachusetts, United States
Life Sciencesector
-founded
Activestatus
View the company profile →

Buyer

Alexion Pharmaceuticals, Inc.
Company · 9 deals on record
  • 2nd transaction in life science
  • 2nd transaction in United States
9deals, all time
3in this sector
2020latest

Seller

Alta Partners
Private equity firm · 126 deals on record
126investments
84in this sector
78exits

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

Orbus Therapeutics, Inc.Same sector and country · Oct 2026
ArtesRx LLCSame sector and country · Aug 2026
Firefly Bio, Inc.Same sector and country · Jul 2026

Questions about this deal

Who acquired Taligen Therapeutics, Inc.?Alexion Pharmaceuticals, Inc. acquired Taligen Therapeutics, Inc. on January 28, 2011.

Who sold Taligen Therapeutics, Inc.?Alta Partners was the seller.

What type of deal was it?It was a add-on acquistion in the life science sector in 2011.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).